Desheng Weng

2.2k total citations
59 papers, 1.2k citations indexed

About

Desheng Weng is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Desheng Weng has authored 59 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 31 papers in Molecular Biology and 19 papers in Immunology. Recurrent topics in Desheng Weng's work include Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (9 papers) and Sarcoma Diagnosis and Treatment (8 papers). Desheng Weng is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (9 papers) and Sarcoma Diagnosis and Treatment (8 papers). Desheng Weng collaborates with scholars based in China, United States and Japan. Desheng Weng's co-authors include Jianlin Gong, Stuart K. Calderwood, Qiuzhong Pan, Baizheng Song, Jian‐Chuan Xia, Shigeo Koido, Zhengrong Wu, Jingjing Zhao, Lirong Wu and Yan Tang and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Oncogene.

In The Last Decade

Desheng Weng

59 papers receiving 1.2k citations

Peers

Countries citing papers authored by Desheng Weng

Since Specialization

Citations

This map shows the geographic impact of Desheng Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Desheng Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Desheng Weng more than expected).

Fields of papers citing papers by Desheng Weng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Desheng Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Desheng Weng. The network helps show where Desheng Weng may publish in the future.

Co-authorship network of co-authors of Desheng Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Desheng Weng. A scholar is included among the top collaborators of Desheng Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Desheng Weng. Desheng Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transformable Tumor Microenvironment‐Responsive Oxygen Vacancy‐Rich MnO ₂ @Hydroxyapatite Nanospheres for Highly Efficient Cancer Sonodynamic Immunotherapy 2025 ·Advanced Science ·(unknown), (unknown), (unknown), Desheng Weng, Jinjun He, (unknown), Yuanyuan Liu, (unknown), James C. Liao, Peng Wang, Xihong Lu, (unknown)	3
2	Epstein-Barr virus causes vascular abnormalities in epithelial malignancies through upregulating ANXA3-HIF-1α-VEGF pathway 2024 ·Oncogene ·Yuanyuan Chen, (unknown), Yan Tang, Jingjing Zhao, Qijing Wang, Zhixing Guo, Yongqiang Li, (unknown), (unknown), Hao Chen, Yan Wang, Desheng Weng, Qiuzhong Pan, Tong Xiang, Jian‐Chuan Xia	5
3	N6-methyladenosine-modified VGLL1 promotes ovarian cancer metastasis through high-mobility group AT-hook 1/Wnt/β-catenin signaling 2024 ·iScience ·(unknown), (unknown), Qiuzhong Pan, Xingyu Jiang, Jingjing Zhao, Tong Xiang, Yan Tang, Qijing Wang, Jia He, Desheng Weng, Yanna Zhang, Zhongqiu Liu, Jian‐Chuan Xia	3
4	Alarmin IL-33 orchestrates antitumoral T cell responses to enhance sensitivity to 5-fluorouracil in colorectal cancer 2023 ·Theranostics ·Mengjia Song, Jieying Yang, (unknown), (unknown), Qiuzhong Pan, (unknown), Tong Xiang, Juan Liu, Yan Tang, Qijing Wang, Yongqiang Li, Jia He, Hao Chen, Jingjing Zhao, Desheng Weng, Yizhuo Zhang, Jian‐Chuan Xia	12
5	Lenvatinib improves anti-PD-1 therapeutic efficacy by promoting vascular normalization via the NRP-1-PDGFRβ complex in hepatocellular carcinoma 2023 ·Frontiers in Immunology ·Jieying Yang, Zhixing Guo, Mengjia Song, Qiuzhong Pan, Jingjing Zhao, (unknown), Yulong Han, (unknown), Chaopin Yang, (unknown), (unknown), Yan Tang, Qian Zhu, Qijing Wang, Yongqiang Li, Jia He, Desheng Weng, Tong Xiang, Jian‐Chuan Xia	13
6	Anlotinib as a maintenance treatment for advanced soft tissue sarcoma after first-line chemotherapy (ALTER-S006): a multicentre, open-label, single-arm, phase 2 trial 2023 ·EClinicalMedicine ·(unknown), Qiuzhong Pan, (unknown), Haomiao Li, Xianan Li, Jing Chen, Danmei Pang, Baoqing Zhang, Desheng Weng, Ruiqing Peng, Meiyu Fang, Xing Zhang	17
7	A Novel Heat Shock Protein 70-Based Vaccine Prepared from DC Tumor Fusion Cells: An Update 2023 ·Methods in molecular biology ·Desheng Weng, Stuart K. Calderwood, Jianlin Gong	1
8	Phase I study of pegylated liposomal doxorubicin and cisplatin in patients with advanced osteosarcoma 2022 ·Cancer Chemotherapy and Pharmacology ·Xizhi Wen, Qiuzhong Pan, (unknown), Wei Xiao, Desheng Weng, Jingjing Zhao, Hairong Xu, (unknown), Xiaohui Niu, Xing Zhang	15
9	CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma 2022 ·Cell Death and Disease ·Yue Huang, (unknown), Jieying Yang, Qiuzhong Pan, Jingjing Zhao, Mengjia Song, Chaopin Yang, Yulong Han, Yan Tang, Qijing Wang, Jia He, Yongqiang Li, Junyi He, (unknown), Desheng Weng, Tong Xiang, Jian‐Chuan Xia	35
10	SPC25 promotes proliferation and stemness of hepatocellular carcinoma cells via the DNA-PK/AKT/Notch1 signaling pathway 2022 ·International Journal of Biological Sciences ·Jieying Yang, (unknown), Mengjia Song, Qiuzhong Pan, Jingjing Zhao, Junyi He, (unknown), Chaopin Yang, Yulong Han, Yan Tang, Qijing Wang, (unknown), Yongqiang Li, Hao Chen, Desheng Weng, Tong Xiang, Jian‐Chuan Xia	23
11	Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma 2021 ·Journal for ImmunoTherapy of Cancer ·Yi Que, Xiao-Long Zhang, Zexian Liu, Jingjing Zhao, Qiuzhong Pan, Xizhi Wen, Wei Xiao, (unknown), Dong‐Chun Hong, (unknown), Lujun Shen, Weijun Fan, Huoying Chen, Desheng Weng, Hairong Xu, Penghui Zhou, Yizhuo Zhang, (unknown), Xing Zhang	67
12	A Novel Heat Shock Protein 70-based Vaccine Prepared from DC-Tumor Fusion Cells 2017 ·Methods in molecular biology ·Desheng Weng, Stuart K. Calderwood, Jianlin Gong	6
13	Quantitative proteome analysis of overexpressed Cripto-1 tumor cell reveals 14-3-3γ as a novel biomarker in nasopharyngeal carcinoma 2013 ·Journal of Proteomics ·Zhengrong Wu, Desheng Weng, Gang Li	13
14	Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers 2012 ·Breast Cancer Research ·Desheng Weng, (unknown), Baizheng Song, Shigeo Koido, Stuart K. Calderwood, Jianlin Gong	53
15	Preparation of a Heat-Shock Protein 70-Based Vaccine from DC–Tumor Fusion Cells 2011 ·Methods in molecular biology ·Desheng Weng, Stuart K. Calderwood, Jianlin Gong	14
16	Radiosensitization of mammary carcinoma cells by telomere homolog oligonucleotide pretreatment 2010 ·Breast Cancer Research ·Desheng Weng, (unknown), Baizheng Song, Brendan D. Price, Mark S. Eller, Barbara A. Gilchrest, Stuart K. Calderwood, Jianlin Gong	13
17	Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene 2010 ·Molecular Cancer ·Haiqing Ma, Desheng Weng, Yibing Chen, Wei Huang, Ke Pan, Hui Wang, Jiancong Sun, Qijing Wang, Zhiwei Zhou, Hui‐Yun Wang, Jian‐Chuan Xia	23
18	Induction of cytotoxic T lymphocytes against ovarian cancer‐initiating cells 2010 ·International Journal of Cancer ·Desheng Weng, Baizheng Song, (unknown), Valerie Sugiyama, (unknown), Shigeo Koido, Stuart K. Calderwood, Jianlin Gong	41
19	Reduced expression of lamin A/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma 2009 ·Journal of Experimental & Clinical Cancer Research ·Zhengrong Wu, Lirong Wu, Desheng Weng, Dazhi Xu, Jian Geng, Fei Zhao	89
20	Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma 2009 ·BMC Cancer ·Zhengrong Wu, Gang Li, Lirong Wu, Desheng Weng, Xiangping Li, Kai‐Tai Yao	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact